Target AudienceThe course is intended for: ● Psychiatrists● Neurologists● Neuropsychiatrists

Course Objectives● Understand the current culture and climate of mental health conditions in the U.S. and Europe● Learn about the latest research and translate that data into your clinical practice● Exchange knowledge with a community of healthcare professionals involved in all levels of care● Advance your clinical knowledge● Enhance your clinical skills● Update your standards of care

www.internationalpsychopharmacology.org | info@internationalpsychopharmacology.org

International Psychopharmacology Course 2017

The Massachusetts General Hospital Psychiatry Academy of Boston and the Università degli Studi di Salerno (University of Salerno) are proud to organize the International Psychopharmacology Course 2017 in Salerno, Italy: a two-day course offering an in-depth review of the latest knowledge in treatment, epidemiology, and diagnosis across mental health conditions including depression, eating disorders, and schizophrenia.

The Massachusetts General Hospital Psychiatry Academy has been hosting the renowned Psychopharmacology Conference in the U.S. for over 40 years. This international course will be interactive and multidisciplinary. It will provide a unique opportunity to understand differing perspectives and approaches from leading mental health experts in the U.S. and Europe, as well as an exceptional forum for networking, exchanging ideas, learning, and sharing experiences with colleagues and faculty.

● Psychologists● General and Family Practice Physicians● Psychiatric Nurses● Physician Assistants

● Nurse Practitioners● Social Workers● Other healthcare professionals interested in the topic

In collaboration with:

International Psychopharmacology Course 2017September 29-30, 2017 | Salerno, Italy

Preliminary AgendaThe Complexity of Depression

• Treatment-resistant Depression• Bipolar Depression • Depression in Neurological Diseases• Withdrawn Behavior and Juvenile Depression• Panel Discussion and Q&A

Eating Disorders: Recent Advances andFuture Perspectives

• Diagnostic Issues and Epidemiology of EDs• The Contribution of Neurosciences to the Neurobiology of EDs• Physical Complications in EDs• Treatment and Outcome of EDs• Panel Discussion and Q&A

Target AudienceThe course is intended for: ● Psychiatrists● Neurologists● Neuropsychiatrists

www.internationalpsychopharmacology.org | info@internationalpsychopharmacology.org

Scientific CommitteeMaurizio FavaHarvard Medical SchoolMassachusetts General Hospital

FacultyAndreas ErfurthOtto-Wagner-Spital

David H. RubinMassachusetts General HospitalMcLean Hospital

Elizabeth LawsonHarvard Medical SchoolMassachusetts General Hospital

Jerrold RosenbaumHarvard Medical SchoolMassachusetts General Hospital

Schizophrenia and Schizophrenia-related Psychoses:A Focus on Treatment Issues

• Early Intervention in Psychosis• Real-life Functioning of Persons with Schizophrenia: Implications for Treatment• Physical Comorbidity in Schizophrenia: Impact of Antipsychotic Treatment• Evolution of Antipsychotic Therapy: Focus on Long-acting Injectable Antipsychotics• Panel Discussion and Q&A

Special Topics• Psychiatric Disorders in Neurological Diseases: When Psychiatry meets Neurology• Current Concepts in the Neurobiology of Attention Deficit Hyperactivity Disorder• Panel Discussion and Q&A

● Psychologists● General and Family Practice Physicians● Psychiatric Nurses● Physician Assistants

● Nurse Practitioners● Social Workers● Other healthcare professionals interested in the topic

Palmiero MonteleoneUniversity of Salerno

Joseph BiedermanHarvard Medical SchoolMassachusetts General Hospital

Kamryn EddyHarvard Medical SchoolMassachusetts General Hospital

Mario MajPast-President WorldPsychiatric AssociationUniversity of Campania "Luigi Vanvitelli"

Oliver FreudenreichHarvard Medical SchoolMassachusetts General Hospital

Palmiero MonteleoneUniversity of Salerno

Paolo BaroneUniversity of Salerno

Silvana GalderisiPresident of the European Psychiatric AssociationUniversity of Campania "Luigi Vanvitelli"

Stefan LeuchtTU-MünchenUniversity of Aarhus

Zeina El-ChemaliHarvard Medical School

Course DirectorsDavid H. RubinMassachusetts General HospitalMcLean Hospital

Palmiero MonteleoneUniversity of Salerno

Early Bird Registration Rates (on or before July 28, 2017)MDs/Doctoral-Level Professionals: €500Other Professionals or Trainees: €400

Regular Registration Rates (after July 28, 2017)MDs/Doctoral-Level Professionals: €550Other Professionals or Trainees: €450

International Psychopharmacology Course 2017September 29-30, 2017 | Salerno, Italy